Skip to content

Non-invasive Spinal Cord Stimulation After Spinal Cord Injury

Non-invasive Spinal Cord Stimulation for Improving Movement: Neuromodulation With Spinal Stimulation Methods and Individualized Locomotor Training

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06260735
Acronym
SCI-ES-WALK
Enrollment
10
Registered
2024-02-15
Start date
2023-06-15
Completion date
2024-11-15
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries, Spinal Cord Diseases

Keywords

Trans-spinal electrical stimulation, Locomotor training, Functional electrical stimulation, Peripheral nerve stimulation

Brief summary

Spinal cord injury (SCI) is a central nervous system injury that often leads to motor dysfunction. Non-invasive electrical stimulation of the spinal cord has been recognized as a potential method of reactivating lost spinal neural networks to improve motor recovery and exercise response after SCI. Trans-spinal electrical stimulation (ts-ES) has been found to increase functional gains in people after SCI when applied in combination with other motor training protocols. This project aims to evaluate the effects of non-invasive lumbar spinal cord electrical stimulation on the motor function of trunk and lower limbs in people with SCI after augmenting their locomotor training (treadmill stepping) with step-cycle-based electrical peripheral neural stimulation methods.

Detailed description

This project will evaluate the effects of non-invasive lumbar ts-ES on locomotor function in people with incomplete motor SCI (iSCI) who retain some ability to stand or walk. This study has 3 phases: Baseline assessment - 2 sessions - week 1 -Lab visits #1-2 Locomotor training with varied electrical stimulation- 12 sessions - weeks 2-5 - Lab visits #3-14 (1hr, x3/week) End of training assessment - 2 sessions - week 6- Lab visits #15-16. Specific locomotor deficits of each participant will be evaluated, and their step-cycle-based peripheral muscle or nerve stimulation strategy will be determined accordingly to improve stance or step capacity. After augmenting their locomotor function with muscle or peripheral nerve stimulation-induced activation strategies that address particular and unique motor deficits, they will receive intermittent bouts of stance or locomotor training supplemented with ts-ES. The locomotor training will consist of standing/walking on a treadmill with appropriate bodyweight support and added muscle or peripheral nerve stimulation. Specifically, the project aims to assess the following: 1. Does combined muscle (NMES) or peripheral nerve (PN) stimulation with ts-ES during treadmill stepping facilitate locomotor performance? 2. Does four weeks of combined training as described above (1hrx3/week) facilitate exercise capacity (measured by submaximal VO2) in persons with chronic iSCI?

Interventions

DEVICETrans-spinal electrical stimulation

Trans-spinal electrical stimulation (ts-ES) at T11-L1 vertebral levels with short pulses at a set frequency (30Hz).

DEVICEElectrical muscle activation

Peripheral nerve (PN) or muscle (NMES) stimulation strategy was developed for each participant to optimize stance/walk capacity based on personal needs/preferences.

Stepping on a treadmill with individually preferred speed.

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Has spinal cord injury, 6 mo or longer since injury * Is between 20 and 65 years of age * Has difficulty with trunk and/or lower limb function * Stable medical condition * Non-progressive etiology of spinal injury * No ventilatory support

Exclusion criteria

* Genetic or degenerative etiology of spinal injury * Need for ventilatory or other life-sustaining medical support * History of cardiovascular or pulmonary complications (heart failure, severe hypertension etc.)

Design outcomes

Primary

MeasureTime frameDescription
Neurophysiological markers or steppingPre-training (on week 1) and within one week from end of training (on week 6)Average step length, step height at ankle (cm).
Electromyography (EMG) of ankle extensor musclesPre-training (on week 1) and within one week from end of training (on week 6)Mean RMS amplitude
Metabolic function testingPre-training (on week 1) and within one week from end of training (on week 6)Breath-by-breath analysis of air in/out will be used to measure VO2max (mL/kg/min).

Secondary

MeasureTime frameDescription
6 Min Walk TestPre-training (on week 1) and within one week from end of training (on week 6)Measure distance (m) covered in 6 min walking, overground with device of choice (if using it at home/in community). Repeat with save device. Verbal encouragement and safety support in place during testing.
Rate or Perceived Exertion (RPE) of Submaximal VO2 testingPre-training (on week 1) and within one week from end of training (on week 6)Borg scale from 6-20 (chart used from Heart Online open source). Scale: 6-20. Lower scores mean less exertion (less tiring).
SCIM-Spinal Cord Independence Measure- Mobility scoresPre-training (on week 1) and within one week from end of training (on week 6)Rick Hansen Institute, Spinal Cord Independence Measure III - Mobility subsection, Questions 12-17. Scale: 0-20. Lower score means less mobility.
Autonomic scoresPre-training (on week 1) and within one week from end of training (on week 6)American Spinal Injury Association-Autonomic Standards assessment form-General Autonomic Function & Lower Urinary tract, bowel, and sexual function components. Scale: 0-48. Lower scores mean less autonomic function.

Countries

Canada

Contacts

Primary ContactKatinka Stecina
katinka.stecina@umanitoba.ca204-789-3761
Backup ContactKristine Cowley
kristine.cowley@umanitoba.ca204-789-3305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026